Harbor Advisory Corp Abbott Laboratories Transaction History

Harbor Advisory Corp

$289 Million
Q2 2024

A detailed history of Harbor Advisory Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Harbor Advisory Corp holds 36,586 shares of ABT stock, worth $4.26 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

36,586

Previous 37,036 1.22%

Holding current value

$4.26 Million

Previous $4.21 Million 9.69%

% of portfolio

1.32%

Previous 1.44%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$100.73 - $112.44 $45,328 - $50,598	-450 Reduced 1.22%	36,586 $3.8 Million
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $33,732 - $37,255	-308 Reduced 0.82%	37,036 $4.21 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $94,879 - $116,140	-1,052 Reduced 2.74%	37,344 $4.11 Million
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $34,390 - $41,263	-360 Reduced 0.93%	38,396 $3.72 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $12,597 - $14,036	-125 Reduced 0.32%	38,756 $4.23 Million
Q1 2023 May 04, 2023	BUY	$96.86 - $114.01 $21,696 - $25,538	224 Added 0.58%	38,881 $3.94 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $3,802 - $4,460	-40 Reduced 0.1%	38,657 $4.24 Million
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $14,320 - $16,580	-148 Reduced 0.38%	38,697 $3.74 Million
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $19,087 - $23,070	187 Added 0.48%	38,845 $4.22 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $114,020 - $139,040	-1,000 Reduced 2.52%	38,658 $4.58 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $32,348 - $39,608	280 Added 0.71%	39,658 $5.58 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $98,913 - $116,435	-935 Reduced 2.32%	39,378 $4.57 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $242,713 - $285,952	2,230 Added 5.86%	40,313 $4.83 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $986,580 - $1.08 Million	9,396 Added 32.75%	38,083 $4.17 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $27,033 - $32,830	-295 Reduced 1.02%	28,687 $3.12 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $135,146 - $172,970	-1,765 Reduced 5.74%	28,982 $2.65 Million
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $24,813 - $36,284	-395 Reduced 1.27%	30,747 $2.43 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $77,410 - $86,176	-986 Reduced 3.07%	31,142 $2.71 Million
Q3 2019 Oct 28, 2019	SELL	$81.84 - $88.74 $18,741 - $20,321	-229 Reduced 0.71%	32,128 $2.69 Million
Q2 2019 Jul 30, 2019	SELL	$72.88 - $85.0 $10,932 - $12,750	-150 Reduced 0.46%	32,357 $2.72 Million
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $52,512 - $63,487	-793 Reduced 2.38%	32,507 $2.6 Million
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $37,434 - $42,408	-571 Reduced 1.69%	33,300 $2.41 Million
Q3 2018 Oct 17, 2018	SELL	$60.81 - $73.36 $4,864 - $5,868	-80 Reduced 0.24%	33,871 $2.49 Million
Q2 2018 Jul 23, 2018	SELL	$57.57 - $63.54 $6,908 - $7,624	-120 Reduced 0.35%	33,951 $2.07 Million
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $41,470 - $46,887	-737 Reduced 2.12%	34,071 $2.04 Million
Q4 2017 Jan 30, 2018	BUY	$53.68 - $57.47 $1.87 Million - $2 Million	34,808	34,808 $1.99 Million

Others Institutions Holding ABT

# of Institutions

3,133

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $204B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Advisory Corp , based on Form 13F filings with the SEC.

News

Stay updated on Harbor Advisory Corp with notifications on news.

Account

Harbor Advisory Corp Abbott Laboratories Transaction History